GILMAN STEVEN C has filed 28 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 23000 shares of SCYNEXIS INC ($SCYX) on June 26, 2025.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 26, 2025 | SCYNEXIS INC | $SCYX | GILMAN STEVEN C | Not found | A | Stock Option | 23000 | $0.00 | 23,000.0000 | 48,513,073 | 9999.99% | 0.05% |
| June 26, 2025 | SCYNEXIS INC | $SCYX | GILMAN STEVEN C | Not found | A | Common stock | 23000 | $0.00 | 70,000.0000 | 48,513,073 | 48.94% | 0.05% |
| June 10, 2025 | Akebia Therapeutics, Inc. | $AKBA | GILMAN STEVEN C | Not found | A | Common Stock | 35700 | $0.00 | 152,830.0000 | 210,946,658 | 30.48% | 0.02% |
| June 10, 2025 | Akebia Therapeutics, Inc. | $AKBA | GILMAN STEVEN C | Not found | A | Stock Option (Right to buy) | 53600 | $0.00 | 53,600.0000 | 210,946,658 | 9999.99% | 0.03% |
| Oct. 16, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | M | Stock Option (Right to Buy) | 5833 | $0.00 | 0.0000 | 49,085,000 | 0.00% | 0.01% |
| Oct. 16, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | M | Common Stock | 5833 | $13.05 | 16,833.0000 | 49,085,000 | 53.03% | 0.01% |
| Oct. 16, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | S | Common Stock | 5833 | $41.36 | 11,000.0000 | 49,085,000 | 34.65% | 0.01% |
| Oct. 2, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | M | Stock Option (Right to Buy) | 5833 | $0.00 | 5,833.0000 | 49,085,000 | 9999.99% | 0.01% |
| Oct. 2, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | S | Common Stock | 5833 | $40.35 | 11,000.0000 | 49,085,000 | 34.65% | 0.01% |
| Oct. 2, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | M | Common Stock | 5833 | $13.05 | 16,833.0000 | 49,085,000 | 53.03% | 0.01% |
| Sept. 18, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | S | Common Stock | 5834 | $45.54 | 11,000.0000 | 47,590,000 | 34.66% | 0.01% |
| Sept. 18, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | M | Stock Option (Right to Buy) | 5834 | $0.00 | 11,666.0000 | 47,590,000 | 100.03% | 0.01% |
| Sept. 18, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | M | Common Stock | 5834 | $13.05 | 16,834.0000 | 47,590,000 | 53.04% | 0.01% |
| Sept. 4, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | S | Common Stock | 5000 | $48.58 | 11,000.0000 | 47,590,000 | 31.25% | 0.01% |
| Sept. 4, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | M | Common Stock | 5000 | $3.74 | 16,000.0000 | 47,590,000 | 45.45% | 0.01% |
| Sept. 4, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | M | Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 47,590,000 | 0.00% | 0.01% |
| June 20, 2024 | SCYNEXIS INC | $SCYX | GILMAN STEVEN C | Not found | A | Common Stock | 23000 | $0.00 | 47,000.0000 | 48,390,582 | 95.83% | 0.05% |
| June 20, 2024 | SCYNEXIS INC | $SCYX | GILMAN STEVEN C | Not found | A | Stock Option | 23000 | $0.00 | 23,000.0000 | 48,390,582 | 9999.99% | 0.05% |
| June 6, 2024 | Akebia Therapeutics, Inc. | $AKBA | GILMAN STEVEN C | Not found | A | Stock Option (Right to buy) | 45000 | $0.00 | 45,000.0000 | 187,465,448 | 9999.99% | 0.02% |
| June 6, 2024 | Akebia Therapeutics, Inc. | $AKBA | GILMAN STEVEN C | Not found | A | Common Stock | 30000 | $0.00 | 117,130.0000 | 187,465,448 | 34.43% | 0.02% |
| May 1, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | A | Stock Option (Right to Buy) | 8000 | $0.00 | 8,000.0000 | 47,590,000 | 9999.99% | 0.02% |
| May 1, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | M | Common Stock | 3200 | $0.00 | 11,000.0000 | 47,590,000 | 41.03% | 0.01% |
| May 1, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | M | Restricted Stock Unit | 3200 | $0.00 | 0.0000 | 47,590,000 | 0.00% | 0.01% |
| May 1, 2024 | Vericel Corp | $VCEL | GILMAN STEVEN C | Not found | A | Restricted Stock Unit | 3200 | $0.00 | 3,200.0000 | 47,590,000 | 9999.99% | 0.01% |
| June 15, 2023 | SCYNEXIS INC | $SCYX | GILMAN STEVEN C | Not found | A | Common Stock | 10000 | $0.00 | 24,000.0000 | 0 | 71.43% | 0.00% |
| June 15, 2023 | SCYNEXIS INC | $SCYX | GILMAN STEVEN C | Not found | A | Stock Option | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | Akebia Therapeutics, Inc. | $AKBA | GILMAN STEVEN C | Not found | A | Common Stock | 30000 | $0.00 | 87,130.0000 | 0 | 52.51% | 0.00% |
| June 6, 2023 | Akebia Therapeutics, Inc. | $AKBA | GILMAN STEVEN C | Not found | A | Stock Option (Right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |